Skip to content
OpenCapital
Get started

CONMED CNMD Share-based compensation expense related to employee stock plans

Share-based compensation expense related to employee stock plans at other companies

Medtronic logo
MedtronicMDT
——
Solventum logo
SolventumSOLV
——
Intuitive Surgical logo
Intuitive SurgicalISRG
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's share-based compensation expense related to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's share-based compensation expense related to employee stock plans?
CONMED (CNMD) reported share-based compensation expense related to employee stock plans of $5.5M in Q1 2026.
How has CONMED's share-based compensation expense related to employee stock plans changed year-over-year?
CONMED's share-based compensation expense related to employee stock plans decreased by 60.3% year-over-year, from $13.86M to $5.5M.
What is the long-term trend for CONMED's share-based compensation expense related to employee stock plans?
Over 4 years (2021 to 2025), CONMED's share-based compensation expense related to employee stock plans has grown at a 14.8% compound annual growth rate (CAGR), from $16.34M to $28.32M.